Bains Harrison M Jr - Net Worth and Insider Trading

Bains Harrison M Jr Net Worth

The estimated net worth of Bains Harrison M Jr is at least $8,436 dollars as of 2024-11-13. Bains Harrison M Jr is the Director of Cara Therapeutics Inc and owns about 25,076 shares of Cara Therapeutics Inc (CARA) stock worth over $8,436. Details can be seen in Bains Harrison M Jr's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bains Harrison M Jr has not made any transactions after 2022-07-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Bains Harrison M Jr

Bains Harrison M Jr Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bains Harrison M Jr owns 3 companies in total, including Cara Therapeutics Inc (CARA) , BG Medicine Inc (BGMD) , and Bristol-Myers Squibb Co (BMY) .

Click here to see the complete history of Bains Harrison M Jr’s form 4 insider trades.

Insider Ownership Summary of Bains Harrison M Jr

Ticker	Comapny	Transaction Date	Type of Owner
CARA	Cara Therapeutics Inc	2022-07-15	director
BGMD	BG Medicine Inc	2014-06-03	director
BMY	Bristol-Myers Squibb Co	2003-07-09	VP & Tax and Treasury

Bains Harrison M Jr Latest Holdings Summary

Bains Harrison M Jr currently owns a total of 1 stock. Bains Harrison M Jr owns 25,076 shares of Cara Therapeutics Inc (CARA) as of July 15, 2022, with a value of $8,436.

Latest Holdings of Bains Harrison M Jr

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
CARA	Cara Therapeutics Inc	2022-07-15	25,076	0.34	8,436

Holding Weightings of Bains Harrison M Jr

Bains Harrison M Jr Form 4 Trading Tracker

According to the SEC Form 4 filings, Bains Harrison M Jr has made a total of 1 transactions in Cara Therapeutics Inc (CARA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Cara Therapeutics Inc is the sale of 7,200 shares on July 15, 2022, which brought Bains Harrison M Jr around $65,160.

Insider Trading History of Bains Harrison M Jr

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Bains Harrison M Jr Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Bains Harrison M Jr Ownership Network

Ownership Network List of Bains Harrison M Jr

No Data

Ownership Network Relation of Bains Harrison M Jr

Bains Harrison M Jr Owned Company Details

What does Cara Therapeutics Inc do?

Who are the key executives at Cara Therapeutics Inc?

Bains Harrison M Jr is the director of Cara Therapeutics Inc. Other key executives at Cara Therapeutics Inc include Chief Medical Officer Joana Goncalves , Sec'y; Chief Compliance & G.C. Scott Terrillion , and VP-Research & Development Menzaghi Frederique Ph.d. .

Cara Therapeutics Inc (CARA) Insider Trades Summary

Over the past 18 months, Bains Harrison M Jr made no insider transaction in Cara Therapeutics Inc (CARA). Other recent insider transactions involving Cara Therapeutics Inc (CARA) include a net sale of 60,412 shares made by Christopher Posner , a net sale of 5,476 shares made by Joana Goncalves , and a net sale of 5,236 shares made by Scott Terrillion .

In summary, during the past 3 months, insiders sold 3,668 shares of Cara Therapeutics Inc (CARA) in total and bought 0 shares, with a net sale of 3,668 shares. During the past 18 months, 74,117 shares of Cara Therapeutics Inc (CARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 74,117 shares.

Cara Therapeutics Inc (CARA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cara Therapeutics Inc Insider Transactions

No Available Data

What does BG Medicine Inc do?

Who are the key executives at BG Medicine Inc?

Bains Harrison M Jr is the director of BG Medicine Inc. Other key executives at BG Medicine Inc include director & 10 percent owner Noubar Afeyan , 10 percent owner Flagship Pioneering Inc. , and 10 percent owner Agtc Advisors Fund Lp .

BG Medicine Inc (BGMD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of BG Medicine Inc (BGMD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BG Medicine Inc (BGMD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

BG Medicine Inc (BGMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

BG Medicine Inc Insider Transactions

No Available Data

What does Bristol-Myers Squibb Co do?

Who are the key executives at Bristol-Myers Squibb Co?

Bains Harrison M Jr is the VP & Tax and Treasury of Bristol-Myers Squibb Co. Other key executives at Bristol-Myers Squibb Co include Chief Medical Offr. & Drug Dev. Samit Hirawat , EVP & Chief Commercial Officer Christopher S. Boerner , and EVP & Corporate Affairs Cari Gallman .

Bristol-Myers Squibb Co (BMY) Insider Trades Summary

Over the past 18 months, Bains Harrison M Jr made no insider transaction in Bristol-Myers Squibb Co (BMY). Other recent insider transactions involving Bristol-Myers Squibb Co (BMY) include a net purchase of 5,071 shares made by Christopher S. Boerner , a net sale of 17,986 shares made by Ann Powell Judge , and a net purchase of 8,500 shares made by Samuels Theodore R. Ii .

In summary, during the past 3 months, insiders sold 700 shares of Bristol-Myers Squibb Co (BMY) in total and bought 1,830 shares, with a net purchase of 1,130 shares. During the past 18 months, 19,418 shares of Bristol-Myers Squibb Co (BMY) were sold and 15,401 shares were bought by its insiders, resulting in a net sale of 4,017 shares.

Bristol-Myers Squibb Co (BMY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Bristol-Myers Squibb Co Insider Transactions

No Available Data

Bains Harrison M Jr Mailing Address

Above is the net worth, insider trading, and ownership report for Bains Harrison M Jr. Currently GuruFocus does not have mailing address information for Bains Harrison M Jr.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.